- Home
- SSTK vs CATX Comparison
SSTK vs CATX Comparison
Compare SSTK & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SSTK | CATX |
|---|---|---|
| Founded | 2003 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 534.9M | 609.4M |
| IPO Year | 2012 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SSTK | CATX |
|---|---|---|
| Price | $16.74 | $5.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $25.00 | $12.20 |
| AVG Volume (30 Days) | 419.5K | ★ 1.6M |
| Earning Date | 05-20-2026 | 04-28-2026 |
| Dividend Yield | ★ 8.22% | N/A |
| EPS Growth | 23.76 | ★ 29.31 |
| EPS | ★ 1.25 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.35 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.03 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.35 | $1.60 |
| 52 Week High | $29.50 | $6.16 |
Technical Indicators
Market Signals| Indicator | SSTK | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 45.92 | 57.49 |
| Support Level | $14.36 | $3.24 |
| Resistance Level | $20.07 | $5.39 |
| Average True Range (ATR) | 0.98 | 0.42 |
| MACD | 0.20 | -0.11 |
| Stochastic Oscillator | 61.14 | 46.83 |
Price Performance
Historical ComparisonAbout SSTK Shutterstock Inc.
Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.